Study of Cellular and Humoral Immunity and Histopathology of Target Tissues Following Newcastle Clone12IR Vaccine Administration in SPF Chickens

1. Afonso C, Miller P, Grund C, Koch G, Peeters B,
Selleck P, et al. Newcastle disease (infection with
Newcastle disease virus). Manual of diagnostic tests and
vaccines for terrestrial animals, 7th ed OIE. 2018:555-74.
2. Alexander D. Newcastle disease and other
paramyxoviruses. Rev Sci Tech. 2008;19(3):443-62.
3. Miller PJ, Koch G. Newcastle disease. In: Swayne
DE, Glisson, J.R., McDougald, L.R., Nolan, L.K., Suarez,
D.L., Nair, V.L., editor. Diseases of poultry. 13 ed:
Wiley-Blackwell in partnership with the American
Association of Avian Pathologists; 2013. p. 89-138.
4. Lee H-J, Kim J-Y, Lee Y-J, Lee E-K, Song B-M,
Lee H-S, et al. A novel avian paramyxovirus (putative
serotype 15) isolated from wild birds. Front Microbiol.
2017;8:786.
5. Wanyana A, Mugimba KK, Bosco OJ, Kirunda H,
Nakavuma JL, Ducatez MF, et al. Genotypic
characterization of Avian paramyxovirus type-1 viruses
isolated from aquatic birds in Uganda. Onderstepoort J
Vet Res. 2018;85(1):1-7.
6. Czeglédi A, Ujvári D, Somogyi E, Wehmann E,
Werner O, Lomniczi B. Third genome size category of
avian paramyxovirus serotype 1 (Newcastle disease virus)
and evolutionary implications. Virus Res. 2006;120(1-
2):36-48.
7. Brown VR, Bevins SN. A review of virulent
Newcastle disease viruses in the United States and the
role of wild birds in viral persistence and spread. Vet Res.
2017;48-68:1-15.
8. Dimitrov KM, Afonso CL, Yu Q, Miller PJ.
Newcastle disease vaccines—A solved problem or a
continuous challenge? Vet Microbiol. 2017;206:126-36.
9. van Boven M, Bouma A, Fabri TH, Katsma E,
Hartog L, Koch G. Herd immunity to Newcastle disease
virus in poultry by vaccination. Avian Pathol.
2008;37(1):1-5.
10. Saif Y. Diseases of Poultry. 12 ed: John Wiley &
Sons; 2009.
11. Reynolds D, Maraqa A. Protective immunity
against Newcastle disease: the role of antibodies specific
to Newcastle disease virus polypeptides. Avian Dis.
2000;44(1):138-44.
12. Burness G, Moher D, Ben-Ezra N, Kelly RJ,
Hasselquist D, Chin EH. Maternal immunization
increases nestling energy expenditure, immune function,
and fledging success in a passerine bird. Biol Open. 2018;
4;7(4):bio028803. doi: 10.1242/bio.028803.
13. Kapczynski DR, King DJ. Protection of chickens
against overt clinical disease and determination of viral
shedding following vaccination with commercially
available Newcastle disease virus vaccines upon
challenge with highly virulent virus from the California
2002 exotic Newcastle disease outbreak. Vaccine.
2005;23(26):3424-33.
14. Mayers J, Mansfield KL, Brown IH. The role of
vaccination in risk mitigation and control of Newcastle
disease in poultry. Vaccine. 2017;35(44):5974-80.
15. Cornax I, Miller PJ, Afonso CL. Characterization
of live LaSota vaccine strain–induced protection in
chickens upon early challenge with a virulent Newcastle
disease virus of heterologous genotype. Avian Dis.
2012;56(3):464-70.
16. Raghul J, Raj GD, Manohar BM, Balachandran C.
Protection of the reproductive tract of young chicks by
Newcastle disease virus-induced haemagglutination
inhibition antibodies. Vet Res Commun. 2006;30(1):95-102.
17. Ebrahimi MM, Shahsavandi S, Moazenijula G,
Shamsara M. Phylogeny and evolution of Newcastle
disease virus genotypes isolated in Asia during 2008–
2011. Virus Genes. 2012;45(1):63-8.
18. Bello MB, Mahamud SNA, Yusoff K, Ideris A,
Hair-Bejo M, Peeters BP, et al. Development of an
effective and stable genotype-matched live attenuated
Newcastle disease virus vaccine based on a novel
naturally recombinant Malaysian isolate using reverse
genetics. Vaccines. 2020;8(2):270.
19. Otiang E, Thumbi SM, Campbell ZA, Njagi LW,
Nyaga PN, Palmer GH. Impact of routine Newcastle
disease vaccination on chicken flock size in smallholder
farms in western Kenya. Plos one. 2021;16(3):1-10.
20. Shahsavandi S, Ebrahimi MM, Tebianain M. The
predominance of Newcastle disease virus genotype VII:
genome diversity or poor cross-immunity of non-matched
Ebrahimi et al / Archives of Razi Institute, Vol. 78, No. 5 (2023) 1421-1429 1429
vaccines. Vaccine Res. 2021;8(2):4-16.
21. Miller PJ, King DJ, Afonso CL, Suarez DL.
Antigenic differences among Newcastle disease virus
strains of different genotypes used in vaccine formulation
affect viral shedding after a virulent challenge. Vaccine.
2007;25(41):7238-46.
22. Yang H-m, Zhao J, Xue J, Yang Y-l, Zhang G-z.
Antigenic variation of LaSota and genotype VII
Newcastle disease virus (NDV) and their efficacy against
challenge with velogenic NDV. Vaccine. 2017;35(1):27-
32.
23. Sultan HA, Talaat S, Elfeil WK, Selim K, Kutkat
MA, Amer SA, et al. Protective efficacy of the Newcastle
disease virus genotype VII–matched vaccine in
commercial layers. Poult Sci. 2020;99(3):1275-86.
24. Sedeik M, Elbestawy A, El-Shall N, Abd El-Hack
M, Saadeldin I, Swelum A. Comparative efficacy of
commercial inactivated Newcastle disease virus vaccines
against Newcastle disease virus genotype VII in broiler
chickens. Poult Sci. 2019;98(5):2000-7.